ArticleThe journal of pathology. Clinical research2018

A gene signature associated with PTEN activation defines good prognosis intermediate risk prostate cancer cases.

Chee W Ong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.